510(k) Report

510(k) · Cleared

Recalled · Class II · 2017

V.a.C. Therapy Systems - Info V.a.C. Therapy Uniy, Model M6257766

K063740510(k) TraditionalCleared Jun 7, 2007171-day reviewClass II21 CFR 878.4780Recalls 4

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Kci USA, Inc. · OMP Negative Pressure Wound Therapy Powered Suction Pump

Cleared on Jun 7, 2007 as substantially equivalent to K032310 (Kinetic Concepts, Inc., 2003) and 1 other predicate after a 171-day review. Its family tree reaches back 4 generations to 1995. 1 later device descends from it. It has been recalled 4 times.

Decided
Jun 7, 2007
Review
171 days
Class
Class II
Product code
OMP
Recalls
4
Predicates
2

Its longest line of descent runs back 4 generations to K945062 (1995). 5 ancestors in all. 1 later device descends from it, 1 citing it directly.

  1. Root · 4 generations backK945062 VacplusKinetic Concepts, Inc. · 1995
  2. 3 generations backK971548 AmbuvacKinetic Concepts, Inc. · 1997
  3. 2 generations backK032310 Mini V.a.C., V.a.C. Freedom, V.a.C. AtsKinetic Concepts, Inc. · 2003 · Recalled
  4. 1 generation backK063426 V.a.C. Ats Large (1000 ML) Canister with Gel, Models M6275093/5…Kci USA, Inc. · 2006
  5. This deviceK063740 V.a.C. Therapy Systems - Info V.a.C. Therapy Uniy, Model M6257766Kci USA, Inc. · 2007
  6. Descendant · cites it directly · 0 of its ownK160487 V.A.C. Rx4 Negative Pressure Wound Therapy (NPWT) SystemKci USA, Inc. · 2016

Most influential descendants

Showing 1 of 1 · See all
  • K160487V.A.C. Rx4 Negative Pressure Wound Therapy (NPWT) SystemKci USA, Inc. · 2016 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K945062VacplusKinetic Concepts, Inc.1995—
−3K971548AmbuvacKinetic Concepts, Inc.1997—
−2K032310Mini V.a.C., V.a.C. Freedom, V.a.C. AtsKinetic Concepts, Inc.20032
−1K063426V.a.C. Ats Large (1000 ML) Canister with Gel, Models M6275093/5, M6275093/10Kci USA, Inc.2006—
0 (this device)K063740V.a.C. Therapy Systems - Info V.a.C. Therapy Uniy, Model M6257766Kci USA, Inc.2007—
+1K160487V.A.C. Rx4 Negative Pressure Wound Therapy (NPWT) SystemKci USA, Inc.2016—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200010

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201610
FIG. 1 — Lineage of K063740, 1995–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OMP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OMP device

  1. #1 K260646 Renasys Edge (66803126)score 15.3 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K032310Mini V.a.C., V.a.C. Freedom, V.a.C. Ats
Summary page 1
…ed V.A.C.® ATS Therapy Unit and the V.A.C. Freedom® Therapy Unit device to which are described in the following 51 0(k)s: equivalence is · K032310 for the V.A.C.® Family of Products (cleared October claimed 10, 2003) · K062227 for…
Kinetic Concepts, Inc.20032
*K063426V.a.C. Ats Large (1000 ML) Canister with Gel, Models M6275093/5, M6275093/10
Summary page 1
…e mechanism of action for inclusion into the Indications for Use statement (cleared October 4, 2006) * In addition, K063426 covers the V.A.C.®ATS 1000 ml canister (cleared December 13, 2006).…
Kci USA, Inc.2006—
†K062227V.a.C. Therapy SystemKci USA, Inc. (Kinetic Concepts, Inc.)20062

Also cleared against K032310: 13 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K160487V.A.C. Rx4 Negative Pressure Wound Therapy (NPWT) SystemKci USA, Inc.20160

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Apr 28, 2017Class IIZ-2171-2017Packaging process controlPotential sterile barrier breach
Nov 4, 2009Not classifiedZ-0666-2010Nonconforming Material/ComponentPower cords may crack and fail inside plug with potential for fire hazard.
Jul 29, 2008Not classifiedZ-2440-2008Equipment maintenanceThe port on the 500mL InfoV.A.C. Canister that connects to the suction pump tubing was found to be partially or fully occluded with plastic.
Jul 29, 2008Not classifiedZ-2439-2008Equipment maintenanceThe port on the 500mL InfoV.A.C. Canister that connects to the suction pump tubing was found to be partially or fully occluded with plastic.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 12 years and passes through 2 companies; a new generation was cleared every 3.2 years on median.
  • 1 of the 5 ancestors has a recall of any class.
  • Of its descendants, K160487 (Kci USA, Inc., 2016) has gone furthest, with 0 descendants of its own.
  • 13 other devices also cite its predicate K032310.

How does its category compare?

All OMP devices

OMP Negative Pressure Wound Therapy Powered Suction Pump: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · OMP

5in 2025

2007: 62008: 82009: 82010: 62011: 62012: 112013: 112014: 102015: 202016: 192017: 112018: 132019: 152020: 62021: 92022: 102023: 82024: 92025: 52026 (partial year): 9
2007high 20 (2015) · low 5 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OMP

127in 2025

2007: 113 days median2008: 98 days median2009: 87 days median2010: 97 days median2011: 123 days median2012: 292 days median2013: 84 days median2014: 179 days median2015: 189 days median2016: 146 days median2017: 137 days median2018: 214 days median2019: 249 days median2020: 179 days median2021: 238 days median2022: 229 days median2023: 291 days median2024: 181 days median2025: 127 days median2026 (partial year): 141 days median
2007high 292 (2012) · low 84 (2013)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OMP

2in 2024

2009: 72010: 32012: 12013: 22014: 42015: 12016: 22019: 12024: 2
2007high 7 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OMP

140in 2025

2007: 12008: 12009: 792010: 802011: 1302012: 972013: 1692014: 2292015: 3782016: 3982017: 3682018: 4222019: 9942020: 3,6642021: 1,4222022: 2582023: 1432024: 1352025: 140
2007high 3,664 (2020) · low 1 (2007)2025

MAUDE reports naming product code OMP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007611301
200889801
2009887779
2010697380
201161230130
201211292197
201311842169
2014101794229
2015201891378
2016191462398
2017111370368
2018132140422
2019152491994
2020617903,664
2021923801,422
2022102290258
202382910143
202491812135
202551270140
202691410—

What is it indicated for?

The V.A.C.® Therapy System is an integrated wound management system for use in acute, extended and home care settings. It is intended to create an environment that promotes wound healing by secondary or tertiary (delayed primary) intention by preparing the wound bed for closure, reducing edema, promoting granulation tissue formation and perfusion, and by removing exudate and infectious material. It is indicated for patients with chronic, acute…

Read the full statement (105 words)

The V.A.C.® Therapy System is an integrated wound management system for use in acute, extended and home care settings. It is intended to create an environment that promotes wound healing by secondary or tertiary (delayed primary) intention by preparing the wound bed for closure, reducing edema, promoting granulation tissue formation and perfusion, and by removing exudate and infectious material. It is indicated for patients with chronic, acute, traumatic, subacute and dehisced wounds, partial-thickness burns, ulcers (such as diabetic or pressure), flaps and grafts.

The V.A.C.® GranuFoam® Silver™ Dressing is an effective barrier to bacterial penetration and may help reduce infection in the above wound types.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K063740: V.a.C. Therapy Systems - Info V.a.C. Therapy Uniy, Model M6257766.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K063740

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026